J&J has already bought cardiovascular companies Abiomed and Laminar for $16.6bn and $400m · Medical Device Network · Michael Vi / Shutterstock. The neurovascular market, estimated at $4.2bn in ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
In a press release, the federal law enforcement agency announced that its now-formerly named Mayagüez Marine Unit has been dedicated the Michel O. Maceda Marine Unit. Advertisement Agent Michel ...
Uniti, an internally managed real estate investment trust, is engaged in the acquisition and construction of mission critical communications infrastructure, and is a leading provider of fiber and ...
J&J’s potential exit from the neurovascular market follows a trend among medtech leaders such as Medtronic and Stryker. Credit: Michael Vi / Shutterstock. The Financial Times recently reported that ...
J&J MedTech Neurovascular Worldwide President Mark Dickinson [Photo courtesy of Johnson & Johnson MedTech] Johnson & Johnson MedTech (NYSE: JNJ) + Neurovascular Worldwide President Mark ...
More than half of patients with ischemic stroke experience futile reperfusion, increasing the risk of death and disabilities despite a successful recanalization. The reason behind this is debated, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback